Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
Clinical trial NCT05377034 · RECRUITING
Trial details
- NCT number
- NCT05377034
- Sponsor
- National Cancer Centre, Singapore
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2026-07-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.